Change log
EU AI Act: what changed
What changes, when, and what it means for pharma, medtech and diagnostics. Every entry carries its date and a link to the official text. I only list what I have checked against the Official Journal of the EU.
-
27 July 2026
Digital Omnibus in force: Article 4 AI literacy rewritten
- What changed
- Before, providers and deployers had to ensure, to their best extent, a sufficient level of AI literacy of their staff. Now they must take measures to support the development of AI literacy, taking into account knowledge, experience, education, training and the context of use. The new text states that no specific level of AI literacy of any individual has to be guaranteed. The Commission and the member states support providers and deployers, in particular SMEs.
- What it means for life sciences
- The obligation stays, its standard changes: measures instead of a guaranteed level. The text does not explicitly require documentation. Being able to show which measures you took, such as training, guidelines and clear responsibilities, is still the practical proof when a customer, an auditor or an authority asks.
- Source
- Regulation (EU) 2026/1744 of 8 July 2026, Official Journal L of 24 July 2026, in force on the third day after publication.
-
27 July 2026
High-risk obligations postponed
- What changed
- The rules for high-risk AI systems (Chapter III, Sections 1 to 3) were due to apply from 2 August 2026, and from 2 August 2027 for products under Annex I. The Digital Omnibus moves them to 2 December 2027 for high-risk systems under Article 6(2) and Annex III, and to 2 August 2028 for those under Article 6(1) and Annex I.
- What it means for life sciences
- AI in medical devices and in vitro diagnostics that need a notified body falls under Annex I and gains one year, until 2 August 2028. AI in areas listed in Annex III, for example recruiting and HR, follows from 2 December 2027. The extra time is preparation time for technical documentation and quality management, not a pause.
- Source
- Regulation (EU) 2026/1744, recitals on the date of application of Chapter III.
-
2 August 2026
Most of the AI Act applies
- What changed
- This is the general date of application of the AI Act. From this date most of its provisions apply, except the high-risk obligations that the Digital Omnibus moved.
- What it means for life sciences
- Every AI system in use now needs a clear answer to one question: is your company the provider or the deployer? The obligations follow from that role.
- Source
- Regulation (EU) 2024/1689, Article 113.
-
2 August 2025
Rules for general-purpose AI models and governance apply
- What changed
- Chapter V on general-purpose AI models applies, together with Chapter VII on governance, Chapter XII on penalties, Chapter III Section 4 on notifying authorities and notified bodies, and Article 78.
- What it means for life sciences
- For most life sciences companies this matters indirectly: the providers of the large language models your teams use now carry obligations of their own. For medical devices, the setup of notified bodies under the AI Act began.
- Source
- Regulation (EU) 2024/1689, Article 113(b).
-
2 February 2025
Prohibited practices and AI literacy apply
- What changed
- Chapters I and II apply: the general provisions, including the AI literacy duty in Article 4, and the prohibited AI practices in Article 5.
- What it means for life sciences
- Article 4 has applied to every company that uses AI since this date. Its wording was changed in July 2026, see the first entry.
- Source
- Regulation (EU) 2024/1689, Article 113(a).
-
1 August 2024
The AI Act enters into force
- What changed
- Regulation (EU) 2024/1689 of 13 June 2024 enters into force on the twentieth day after its publication. Its rules apply in stages.
- What it means for life sciences
- The clock starts. The staged dates above all count from this regulation.
- Source
- Regulation (EU) 2024/1689, Article 113.
Not legal advice. This log summarises the official texts and adds my assessment for life sciences. For your own product, your regulatory affairs team or a lawyer decides. How my free checks apply these rules is explained on the methodology page.
What does this mean for your company?
In a free 30-minute call we look at your AI systems, your role and your next date.